Intercure director reports 15,000 options at $3.10
Intercure Ltd. director Granot Alon Shmuel reported an initial holding of share options giving the right to buy 15,000 Ordinary Shares.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Intercure Ltd. director Granot Alon Shmuel reported an initial holding of share options giving the right to buy 15,000 Ordinary Shares. These options carry an exercise price of $3.10 per share, based on converting a NIS 9.50 price at an exchange rate of NIS 3.06 to $1.00. The options were granted on September 5, 2024, vest quarterly over four years from the grant date, and expire on September 5, 2028.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Share options (right to buy) | -- | -- | -- |
Footnotes (1)
- F1. The options were granted on September 5, 2024, and the current exercise price is NIS 9.50 per share. For purposes of this Form 3, the exercise price has been converted into U.S. dollars using an exchange rate of NIS 3.06 to USD $1.00 as of April 14, 2026, resulting in an exercise price of $3.10 per share. The options vest on a quarterly basis over four years from the date of grant.
Key Figures
Key Terms
exercise price financial
vesting financial
Form 3 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider position does Granot Alon Shmuel report on Intercure (INCR) Form 3?
What is the exercise price of Granot Alon Shmuel’s Intercure (INCR) options?
When do Granot Alon Shmuel’s Intercure (INCR) options vest and expire?
Does the Intercure (INCR) Form 3 show any recent insider buying or selling?
AI-generated analysis. How Rhea-AI works. Not financial advice.